Mapping Mortality: State-Level Gaps in Heart Failure (HF) and HF Comorbid COPD Deaths in US: A 21-Year CDC Wonder Study
Document Type
Conference Proceeding
Publication Date
4-1-2025
Publication Title
Journal of the American College of Cardiology
Abstract
Background: Heart failure (HF) mortality rates vary notably across U.S. states. This study examines state-level disparities in HF & HF with comorbid chronic obstructive pulmonary disease (COPD) mortality from 1999-2020. Methods: From CDC WONDER database, HF-related deaths among U.S. adults aged ≥25 years were analyzed state-wise & Age Adjusted Mortality Rates (AAMRs) were calculated. Statistical significance was assessed by CI. Results: HF-related AAMRs among U.S. states, ranged from 86.9 (95% CI: 85.7-88.1) in Hawaii to 233.5 (95% CI: 232.1-235.0) in Mississippi, per 100,000. States like Arkansas, Kentucky, West Virginia, Oklahoma & Mississippi had twice the AAMRs than Hawaii, Florida, District of Columbia, Arizona & Nevada. HF & COPD-related AAMRs ranged from 41.5 (95% CI: 40.8-42.2) in West Virginia to 10.5(95% CI: 10.1-10.9) in Hawaii, per 100,000. States like Indiana, Kentucky, Mississippi, Oklahoma & West Virginia had twice the AAMRs than Arizona, District of Columbia, Florida, New Jersey & Utah. HF & HF-COPD mortality may correlate as there was a notable overlap in high AAMR states, while District of Columbia & Florida had low AAMRs. Conclusion: The analysis shows notable state-level disparities in HF & HF with COPD-related mortality in the U.S. from 1999-2020. Mississippi, West Virginia & Kentucky had the highest AAMRs, while Hawaii, Florida, etc. had the lowest. The findings highlight the need for targeted interventions to address disparities & improve outcomes in states with high AAMRs.
Volume
85
Issue
12 Suppl
First Page
1625
Last Page
1625
Recommended Citation
Ahmed F, Ali F, Mirza TR, Chandrani N, Ishaq S, Eltawansy S, et al. [Bonkowski T]. Mapping mortality: state-level gaps in heart failure (HF) and HF comorbid COPD deaths in US: a 21-year CDC Wonder study. J Am Coll Cardiol. 2025 Apr 1;85(12 Suppl):1625. doi:10.1016/S0735-1097(25)02109-6
DOI
10.1016/S0735-1097(25)02109-6
Comments
American College of Cardiology Meeting, March 29-31, 2025, Chicago, IL